These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37773454)

  • 1. The role of galectin-3 in atrial fibrillation.
    Procyk G; Czapla A; Jałocha K; Tymińska A; Grabowski M; Gąsecka A
    J Mol Med (Berl); 2023 Dec; 101(12):1481-1492. PubMed ID: 37773454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation.
    Kornej J; Schmidl J; Ueberham L; John S; Daneschnejad S; Dinov B; Hindricks G; Adams V; Husser D; Bollmann A
    PLoS One; 2015; 10(4):e0123574. PubMed ID: 25875595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease.
    Wu XY; Li SN; Wen SN; Nie JG; Deng WN; Bai R; Liu N; Tang RB; Zhang T; Du X; Dong JZ; Ma CS
    Europace; 2015 Oct; 17(10):1541-7. PubMed ID: 25921557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation.
    Wang Q; Xu L; Dong Y; Fu Y; Pan Y; Luan Q; Liu Y; Liu Z; Yang X; Chen M; Gao Y
    BMC Cardiovasc Disord; 2021 May; 21(1):226. PubMed ID: 33934700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
    Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
    Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.
    Berger WR; Jagu B; van den Berg NWE; Chan Pin Yin DRPP; van Straalen JP; de Boer OJ; Driessen AHG; Neefs J; Krul SPJ; van Boven WP; van der Wal AC; de Groot JR
    Europace; 2018 May; 20(5):764-771. PubMed ID: 28525549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Galectin-3 and Atrial Fibrillation Recurrence after Catheter Ablation: A Meta-Analysis.
    Zhang G; Wu Y
    Cardiovasc Ther; 2019; 2019():4148129. PubMed ID: 31772609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation.
    Mohtasham Kia Y; Cannavo A; Bahiraie P; Alilou S; Saeedian B; Babajani N; Ghondaghsaz E; Khalaji A; Behnoush AH
    Dis Markers; 2023; 2023():2097012. PubMed ID: 37849915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Galectin-3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation.
    Ruan ZB; Gao RF; Wang F; Chen GC; Zhu JG; Ren Y; Zhu L
    Cardiovasc Ther; 2022; 2022():6993904. PubMed ID: 35692374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 in patients with atrial fibrillation and restored sinus rhythm.
    Kisheva A; Yotov Y; Chervenkov T; Angelov A; Bocheva Y
    Folia Med (Plovdiv); 2021 Jun; 63(3):329-336. PubMed ID: 34196141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation.
    López-Canoa JN; Couselo-Seijas M; González-Ferrero T; Almengló C; Álvarez E; González-Maestro A; González-Melchor L; Martínez-Sande JL; García-Seara J; Fernández-López J; Kreidieh B; González-Babarro E; González-Juanatey JR; Eiras S; Rodríguez-Mañero M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Galectin-3 is Associated With Left Atrial Appendage Remodelling and Thrombus Formation in Patients With Atrial Fibrillation.
    Tang Z; Zeng L; Lin Y; Han Z; Gu J; Wang C; Zhang H
    Heart Lung Circ; 2019 Jun; 28(6):923-931. PubMed ID: 29861319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin 3 and incident atrial fibrillation in the community.
    Ho JE; Yin X; Levy D; Vasan RS; Magnani JW; Ellinor PT; McManus DD; Lubitz SA; Larson MG; Benjamin EJ
    Am Heart J; 2014 May; 167(5):729-34.e1. PubMed ID: 24766984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of galectin-3 in patients with permanent and paroxysmal Atrial Fibrillation and echocardiographic parameters of left atrial fibrosis.
    Mariana Barros Melo da Silveira M; Victor Batista Cabral J; Tavares Xavier A; Palmeira do Ó K; Francisco de Moura Junior J; Tavares de Carvalho O; Bezerra Mendes Filho E; Furtado de Mendonça Belmont T; Maria Del Castillo J; Jesus Barreto de Melo Rêgo M; Richardson da Silva Vasconcelos L; Celestino Sobral Filho D; Cavalcanti de Oliveira D
    Mol Biol Rep; 2023 Nov; 50(11):9019-9027. PubMed ID: 37716919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes.
    Takemoto Y; Ramirez RJ; Yokokawa M; Kaur K; Ponce-Balbuena D; Sinno MC; Willis BC; Ghanbari H; Ennis SR; Guerrero-Serna G; Henzi BC; Latchamsetty R; Ramos-Mondragon R; Musa H; Martins RP; Pandit SV; Noujaim SF; Crawford T; Jongnarangsin K; Pelosi F; Bogun F; Chugh A; Berenfeld O; Morady F; Oral H; Jalife J
    JACC Basic Transl Sci; 2016 Apr; 1(3):143-154. PubMed ID: 27525318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Galectin-3 in Patients With Paroxysmal and Persistent Atrial Fibrillation and Metabolic Syndrome].
    A VA; Zaslavskaya EL; Soboleva AV; Baranova EI; Listopad OV; Nifontov SE; Nrady AO; Shlyakhto EV
    Kardiologiia; 2016 Jun; 56(6):41-45. PubMed ID: 28290846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis.
    Gong M; Cheung A; Wang QS; Li G; Goudis CA; Bazoukis G; Lip GYH; Baranchuk A; Korantzopoulos P; Letsas KP; Tse G; Liu T
    J Clin Lab Anal; 2020 Mar; 34(3):e23104. PubMed ID: 31917884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 in Acute Myocardial Infarction Patients with Atrial Fibrillation.
    Stanojevic D; Apostolovic S; Stokanovic D; Momčilović S; Jevtovic-Stoimenov T; Salinger-Martinovic S; Kostic T; Nikolic VN
    Med Princ Pract; 2019; 28(3):284-290. PubMed ID: 30726858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure.
    Clementy N; Garcia B; André C; Bisson A; Benhenda N; Pierre B; Bernard A; Fauchier L; Piver E; Babuty D
    PLoS One; 2018; 13(8):e0201517. PubMed ID: 30067817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.
    Gürses KM; Yalçın MU; Koçyiğit D; Canpınar H; Ateş AH; Canpolat U; Yorgun H; Güç D; Aytemir K
    Turk Kardiyol Dern Ars; 2019 Oct; 47(7):564-571. PubMed ID: 31582678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.